These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27016391)

  • 41. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.
    Li Y; Zhang Y; Li S; Lu J; Chen J; Wang Y; Li Y; Xu J; Li X
    Sci Rep; 2015 Mar; 5():8790. PubMed ID: 25739977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
    Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
    BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer.
    Huang KT; Takano EA; Mikeska T; Byrne DJ; Dobrovic A; Fox SB
    Breast Cancer Res Treat; 2011 Nov; 130(1):319-29. PubMed ID: 21755341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.
    Cheishvili D; Stefanska B; Yi C; Li CC; Yu P; Arakelian A; Tanvir I; Khan HA; Rabbani S; Szyf M
    Oncotarget; 2015 Oct; 6(32):33253-68. PubMed ID: 26427334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours.
    Maleva Kostovska I; Jakimovska M; Popovska-Jankovic K; Kubelka-Sabit K; Karagjozov M; Plaseska-Karanfilska D
    Pathol Oncol Res; 2018 Oct; 24(4):937-940. PubMed ID: 29524167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent methylation of the KLOTHO gene and overexpression of the FGFR4 receptor in invasive ductal carcinoma of the breast.
    Dallol A; Buhmeida A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Elaimi A; Assidi M; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Alkhayyat SS; Al-Qahtani MH
    Tumour Biol; 2015 Dec; 36(12):9677-83. PubMed ID: 26152288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer.
    Li X; Cowell JK; Sossey-Alaoui K
    Oncogene; 2004 Feb; 23(7):1474-80. PubMed ID: 14973555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mathematical deconvolution uncovers the genetic regulatory signal of cancer cellular heterogeneity on resistance to paclitaxel.
    Morilla I; Ranea JA
    Mol Genet Genomics; 2017 Aug; 292(4):857-869. PubMed ID: 28386641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The MOBSTER R package for tumour subclonal deconvolution from bulk DNA whole-genome sequencing data.
    Caravagna G; Sanguinetti G; Graham TA; Sottoriva A
    BMC Bioinformatics; 2020 Nov; 21(1):531. PubMed ID: 33203356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic assessment of cell type deconvolution algorithms for DNA methylation data.
    Song J; Kuan PF
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36242584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.
    Scherer M; Nazarov PV; Toth R; Sahay S; Kaoma T; Maurer V; Vedeneev N; Plass C; Lengauer T; Walter J; Lutsik P
    Nat Protoc; 2020 Oct; 15(10):3240-3263. PubMed ID: 32978601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation profiling reveals a predominant immune component in breast cancers.
    Dedeurwaerder S; Desmedt C; Calonne E; Singhal SK; Haibe-Kains B; Defrance M; Michiels S; Volkmar M; Deplus R; Luciani J; Lallemand F; Larsimont D; Toussaint J; Haussy S; Rothé F; Rouas G; Metzger O; Majjaj S; Saini K; Putmans P; Hames G; van Baren N; Coulie PG; Piccart M; Sotiriou C; Fuks F
    EMBO Mol Med; 2011 Dec; 3(12):726-41. PubMed ID: 21910250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating genome-wide DNA methylation heterogeneity with methylation patterns.
    Lin PY; Chang YT; Huang YC; Chen PY
    Epigenetics Chromatin; 2023 Nov; 16(1):44. PubMed ID: 37941029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pan-cancer deconvolution of tumour composition using DNA methylation.
    Chakravarthy A; Furness A; Joshi K; Ghorani E; Ford K; Ward MJ; King EV; Lechner M; Marafioti T; Quezada SA; Thomas GJ; Feber A; Fenton TR
    Nat Commun; 2018 Aug; 9(1):3220. PubMed ID: 30104673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software.
    Decamps C; Privé F; Bacher R; Jost D; Waguet A; ; Houseman EA; Lurie E; Lutsik P; Milosavljevic A; Scherer M; Blum MGB; Richard M
    BMC Bioinformatics; 2020 Jan; 21(1):16. PubMed ID: 31931698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities.
    Esparza-López J; Escobar-Arriaga E; Soto-Germes S; Ibarra-Sánchez MJ
    Rev Invest Clin; 2017; 69(2):66-76. PubMed ID: 28453505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MethylResolver-a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents.
    Arneson D; Yang X; Wang K
    Commun Biol; 2020 Aug; 3(1):422. PubMed ID: 32747663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deconvolution of tumor composition using partially available DNA methylation data.
    He D; Chen M; Wang W; Song C; Qin Y
    BMC Bioinformatics; 2022 Aug; 23(1):355. PubMed ID: 36002797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HiTIMED: hierarchical tumor immune microenvironment epigenetic deconvolution for accurate cell type resolution in the tumor microenvironment using tumor-type-specific DNA methylation data.
    Zhang Z; Wiencke JK; Kelsey KT; Koestler DC; Christensen BC; Salas LA
    J Transl Med; 2022 Nov; 20(1):516. PubMed ID: 36348337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.